{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T01:44:55Z","timestamp":1791942295122,"version":"4.3.4"},"reference-count":50,"publisher":"Baishideng Publishing Group Inc.","issue":"46","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["WJG"],"published-print":{"date-parts":[[2009]]},"DOI":"10.3748\/wjg.15.5789","type":"journal-article","created":{"date-parts":[[2009,12,10]],"date-time":"2009-12-10T07:03:51Z","timestamp":1260428631000},"page":"5789","source":"Crossref","is-referenced-by-count":50,"title":["Role of the receptor for advanced glycation end products inhepatic fbrosis"],"prefix":"10.3748","volume":"15","author":[{"given":"Christina","family":"Lohwasser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Neureiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury","family":"Popov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Schuppan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2060","reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Schmidt AM, Yan SD, Stern DM. The dark side of glucose. Nat Med 1995;1:1002-1004.","DOI":"10.1038\/nm1095-1002"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Rahbar S, Blumenfeld O, Ranney HM. Studies of an unusual hemoglobin in patients with diabetes mellitus. Biochem Biophys Res Commun 1969;36:838-843.","DOI":"10.1016\/0006-291X(69)90685-8"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Kirstein M, Brett J, Radoff S, Ogawa S, Stern D, Vlassara H. Advanced protein glycosylation induces transendothelial human monocyte chemotaxis and secretion of platelet-derived growth factor: role in vascular disease of diabetes and aging. Proc Natl Acad Sci USA 1990;87:9010-9014.","DOI":"10.1073\/pnas.87.22.9010"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Kislinger T, Fu C, Huber B, Qu W, Taguchi A, Du Yan S, Hofmann M, Yan SF, Pischetsrieder M, Stern D. N(epsilon)-(carboxymethyl)lysine adducts of proteins are ligands for receptor for advanced glycation end products that activate cell signaling pathways and modulate gene expression. J Biol Chem 1999;274:31740-31749.","DOI":"10.1074\/jbc.274.44.31740"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Horiuchi S, Sakamoto Y, Sakai M. Scavenger receptors for oxidized and glycated proteins. Amino Acids 2003;25:283-292.","DOI":"10.1007\/s00726-003-0029-5"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Iacobini C, Amadio L, Oddi G, Ricci C, Barsotti P, Missori S, Sorcini M, Di Mario U, Pricci F, Pugliese G. Role of galectin-3 in diabetic nephropathy. J Am Soc Nephrol 2003;14:S264-S270.","DOI":"10.1097\/01.ASN.0000077402.95720.B4"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Jerums G, Panagiotopoulos S, Forbes J, Osicka T, Cooper M. Evolving concepts in advanced glycation, diabetic nephropathy, and diabetic vascular disease. Arch Biochem Biophys 2003;419:55-62.","DOI":"10.1016\/j.abb.2003.08.017"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Forbes JM, Thallas V, Thomas MC, Founds HW, Burns WC, Jerums G, Cooper ME. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes. FASEB J 2003;17:1762-1764.","DOI":"10.1096\/fj.02-1102fje"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"Bohlender JM, Franke S, Stein G, Wolf G. Advanced glycation end products and the kidney. Am J Physiol Renal Physiol 2005;289:F645-F659.","DOI":"10.1152\/ajprenal.00398.2004"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD Single Topic Conference. Hepatology 2003;37:1202-1219.","DOI":"10.1053\/jhep.2003.50193"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"Wanless IR, Shiota K. The pathogenesis of nonalcoholic steatohepatitis and other fatty liver diseases: a four-step model including the role of lipid release and hepatic venular obstruction in the progression to cirrhosis. Semin Liver Dis 2004;24:99-106.","DOI":"10.1055\/s-2004-823104"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Sanyal AJ, Campbell-Sargent C, Mirshahi F, Rizzo WB, Contos MJ, Sterling RK, Luketic VA, Shiffman ML, Clore JN. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology 2001;120:1183-1192.","DOI":"10.1053\/gast.2001.23256"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"Cataldegirmen G, Zeng S, Feirt N, Ippagunta N, Dun H, Qu W, Lu Y, Rong LL, Hofmann MA, Kislinger T. RAGE limits regeneration after massive liver injury by coordinated suppression of TNF-alpha and NF-kappaB. J Exp Med 2005;201:473-484.","DOI":"10.1084\/jem.20040934"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Fehrenbach H, Weiskirchen R, Kasper M, Gressner AM. Up-regulated expression of the receptor for advanced glycation end products in cultured rat hepatic stellate cells during transdifferentiation to myofibroblasts. Hepatology 2001;34:943-952.","DOI":"10.1053\/jhep.2001.28788"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"Bataller R, Brenner DA. Liver fibrosis. J Clin Invest 2005;115:209-218.","DOI":"10.1172\/JCI24282"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Friedman SL. Mechanisms of hepatic fibrogenesis. Gastroenterology 2008;134:1655-1669.","DOI":"10.1053\/j.gastro.2008.03.003"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"Schuppan D, Afdhal NH. Liver cirrhosis. Lancet 2008;371:838-851.","DOI":"10.1016\/S0140-6736(08)60383-9"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"Iwamoto K, Kanno K, Hyogo H, Yamagishi S, Takeuchi M, Tazuma S, Chayama K. Advanced glycation end products enhance the proliferation and activation of hepatic stellate cells. J Gastroenterol 2008;43:298-304.","DOI":"10.1007\/s00535-007-2152-7"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"Jakus V, Rietbrock N. Advanced glycation end-products and the progress of diabetic vascular complications. Physiol Res 2004;53:131-142.","DOI":"10.33549\/physiolres.930430"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"Lohwasser C, Neureiter D, Weigle B, Kirchner T, Schuppan D. The receptor for advanced glycation end products is highly expressed in the skin and upregulated by advanced glycation end products and tumor necrosis factor-alpha. J Invest Dermatol 2006;126:291-299.","DOI":"10.1038\/sj.jid.5700070"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"Fields R. The rapid determination of amino groups with TNBS. Methods in Enzymology 1972;25:464-468.","DOI":"10.1016\/S0076-6879(72)25042-X"},{"key":"ref22","doi-asserted-by":"crossref","unstructured":"Vogel S, Piantedosi R, Frank J, Lalazar A, Rockey DC, Friedman SL, Blaner WS. An immortalized rat liver stellate cell line (HSC-T6): a new cell model for the study of retinoid metabolism in vitro. J Lipid Res 2000;41:882-893.","DOI":"10.1016\/S0022-2275(20)32030-7"},{"key":"ref23","unstructured":"Rojkind M, Novikoff PM, Greenwel P, Rubin J, Rojas-Valencia L, de Carvalho AC, Stockert R, Spray D, Hertzberg EL, Wolkoff AW. Characterization and functional studies on rat liver fat-storing cell line and freshly isolated hepatocyte coculture system. Am J Pathol 1995;146:1508-1520."},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Casini A, Pinzani M, Milani S, Grappone C, Galli G, Jezequel AM, Schuppan D, Rotella CM, Surrenti C. Regulation of extracellular matrix synthesis by transforming growth factor beta 1 in human fat-storing cells. Gastroenterology 1993;105:245-253.","DOI":"10.1016\/0016-5085(93)90033-9"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"Seglen PO. Hepatocyte suspensions and cultures as tools in experimental carcinogenesis. J Toxicol Environ Health 1979;5:551-560.","DOI":"10.1080\/15287397909529766"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"Dan Z, Popov Y, Patsenker E, Preimel D, Liu C, Wang XD, Seitz HK, Schuppan D, Stickel F. Hepatotoxicity of alcohol-induced polar retinol metabolites involves apoptosis via loss of mitochondrial membrane potential. FASEB J 2005;19:845-847.","DOI":"10.1096\/fj.04-2809fje"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"Popov Y, Patsenker E, Bauer M, Niedobitek E, Schulze-Krebs A, Schuppan D. Halofuginone induces matrix metalloproteinases in rat hepatic stellate cells via activation of p38 and NFkappaB. J Biol Chem 2006;281:15090-15098.","DOI":"10.1074\/jbc.M600030200"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"Srikrishna G, Huttunen HJ, Johansson L, Weigle B, Yamaguchi Y, Rauvala H, Freeze HH. N -Glycans on the receptor for advanced glycation end products influence amphoterin binding and neurite outgrowth. J Neurochem 2002;80:998-1008.","DOI":"10.1046\/j.0022-3042.2002.00796.x"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"van Gijlswijk RP, Wiegant J, Raap AK, Tanke HJ. Improved localization of fluorescent tyramides for fluorescence in situ hybridization using dextran sulfate and polyvinyl alcohol. J Histochem Cytochem 1996;44:389-392.","DOI":"10.1177\/44.4.8601698"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Benten D, Kumaran V, Joseph B, Schattenberg J, Popov Y, Schuppan D, Gupta S. Hepatocyte transplantation activates hepatic stellate cells with beneficial modulation of cell engraftment in the rat. Hepatology 2005;42:1072-1081.","DOI":"10.1002\/hep.20889"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"Popov Y, Patsenker E, Fickert P, Trauner M, Schuppan D. Mdr2 (Abcb4)-\/- mice spontaneously develop severe biliary fibrosis via massive dysregulation of pro- and antifibrogenic genes. J Hepatol 2005;43:1045-1054.","DOI":"10.1016\/j.jhep.2005.06.025"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"D&ouml;tsch J, Hogen N, Ny&uacute;l Z, H&auml;nze J, Knerr I, Kirschbaum M, Rascher W. Increase of endothelial nitric oxide synthase and endothelin-1 mRNA expression in human placenta during gestation. Eur J Obstet Gynecol Reprod Biol 2001;97:163-167.","DOI":"10.1016\/S0301-2115(00)00532-7"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"Patsenker E, Popov Y, Wiesner M, Goodman SL, Schuppan D. Pharmacological inhibition of the vitronectin receptor abrogates PDGF-BB-induced hepatic stellate cell migration and activation in vitro. J Hepatol 2007;46:878-887.","DOI":"10.1016\/j.jhep.2006.11.011"},{"key":"ref34","unstructured":"Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky D, Nowygrod R, Neeper M, Przysiecki C, Shaw A. Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 1993;143:1699-1712."},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Xia JR, Liu NF, Zhu NX. Specific siRNA Targeting the Receptor for Advanced Glycation End Products Inhibits Experimental Hepatic Fibrosis in Rats. Int J Mol Sci 2008;9:638-661.","DOI":"10.3390\/ijms9040638"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Oldfield MD, Bach LA, Forbes JM, Nikolic-Paterson D, McRobert A, Thallas V, Atkins RC, Osicka T, Jerums G, Cooper ME. Advanced glycation end products cause epithelial-myofibroblast transdifferentiation via the receptor for advanced glycation end products (RAGE). J Clin Invest 2001;108:1853-1863.","DOI":"10.1172\/JCI11951"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Twigg SM, Chen MM, Joly AH, Chakrapani SD, Tsubaki J, Kim HS, Oh Y, Rosenfeld RG. Advanced glycosylation end products up-regulate connective tissue growth factor (insulin-like growth factor-binding protein-related protein 2) in human fibroblasts: a potential mechanism for expansion of extracellular matrix in diabetes mellitus. Endocrinology 2001;142:1760-1769.","DOI":"10.1210\/endo.142.5.8141"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"Nakamura S, Niwa T. Advanced glycation end-products and peritoneal sclerosis. Semin Nephrol 2004;24:502-505.","DOI":"10.1016\/j.semnephrol.2004.06.027"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"Huang JS, Guh JY, Chen HC, Hung WC, Lai YH, Chuang LY. Role of receptor for advanced glycation end-product (RAGE) and the JAK\/STAT-signaling pathway in AGE-induced collagen production in NRK-49F cells. J Cell Biochem 2001;81:102-113.","DOI":"10.1002\/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO;2-Y"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"De Vriese AS, Flyvbjerg A, Mortier S, Tilton RG, Lameire NH. Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc Nephrol 2003;14:2109-2118.","DOI":"10.1681\/ASN.V1482109"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Tanaka N, Yonekura H, Yamagishi S, Fujimori H, Yamamoto Y, Yamamoto H. The receptor for advanced glycation end products is induced by the glycation products themselves and tumor necrosis factor-alpha through nuclear factor-kappa B, and by 17beta-estradiol through Sp-1 in human vascular endothelial cells. J Biol Chem 2000;275:25781-25790.","DOI":"10.1074\/jbc.M001235200"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Soulis T, Thallas V, Youssef S, Gilbert RE, McWilliam BG, Murray-McIntosh RP, Cooper ME. Advanced glycation end products and their receptors co-localise in rat organs susceptible to diabetic microvascular injury. Diabetologia 1997;40:619-628.","DOI":"10.1007\/s001250050725"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Schmidt AM, Yan SD, Wautier JL, Stern D. Activation of receptor for advanced glycation end products: a mechanism for chronic vascular dysfunction in diabetic vasculopathy and atherosclerosis. Circ Res 1999;84:489-497.","DOI":"10.1161\/01.RES.84.5.489"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"Cipollone F, Iezzi A, Fazia M, Zucchelli M, Pini B, Cuccurullo C, De Cesare D, De Blasis G, Muraro R, Bei R. The receptor RAGE as a progression factor amplifying arachidonate-dependent inflammatory and proteolytic response in human atherosclerotic plaques: role of glycemic control. Circulation 2003;108:1070-1077.","DOI":"10.1161\/01.CIR.0000086014.80477.0D"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"Ekong U, Zeng S, Dun H, Feirt N, Guo J, Ippagunta N, Guarrera JV, Lu Y, Weinberg A, Qu W. Blockade of the receptor for advanced glycation end products attenuates acetaminophen-induced hepatotoxicity in mice. J Gastroenterol Hepatol 2006;21:682-688.","DOI":"10.1111\/j.1440-1746.2006.04225.x"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"Zeng S, Feirt N, Goldstein M, Guarrera J, Ippagunta N, Ekong U, Dun H, Lu Y, Qu W, Schmidt AM. Blockade of receptor for advanced glycation end product (RAGE) attenuates ischemia and reperfusion injury to the liver in mice. Hepatology 2004;39:422-432.","DOI":"10.1002\/hep.20045"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Geerts A. History, heterogeneity, developmental biology, and functions of quiescent hepatic stellate cells. Semin Liver Dis 2001;21:311-335.","DOI":"10.1055\/s-2001-17550"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Hofmann MA, Drury S, Fu C, Qu W, Taguchi A, Lu Y, Avila C, Kambham N, Bierhaus A, Nawroth P. RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100\/calgranulin polypeptides. Cell 1999;97:889-901.","DOI":"10.1016\/S0092-8674(00)80801-6"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Valencia JV, Mone M, Zhang J, Weetall M, Buxton FP, Hughes TE. Divergent pathways of gene expression are activated by the RAGE ligands S100b and AGE-BSA. Diabetes 2004;53:743-751.","DOI":"10.2337\/diabetes.53.3.743"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"Hyogo H, Yamagishi S, Iwamoto K, Arihiro K, Takeuchi M, Sato T, Ochi H, Nonaka M, Nabeshima Y, Inoue M. Elevated levels of serum advanced glycation end products in patients with non-alcoholic steatohepatitis. J Gastroenterol Hepatol 2007;22:1112-1119.","DOI":"10.1111\/j.1440-1746.2007.04943.x"}],"container-title":["World Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i46\/5789.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,27]],"date-time":"2023-05-27T21:13:36Z","timestamp":1685222016000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.wjgnet.com\/1007-9327\/full\/v15\/i46\/5789.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009]]},"references-count":50,"journal-issue":{"issue":"46","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.3748\/wjg.15.5789","relation":{},"ISSN":["1007-9327"],"issn-type":[{"value":"1007-9327","type":"print"}],"subject":[],"published":{"date-parts":[[2009]]}}}